In comparison to HS, both PD-dn and PD-dt patients had lower levels of TBX21, STAT3, STAT4, and NR4A2, and higher levels of STAT6, GATA3, and FOXP3 (Fig. 3). This evidence concerns the gene NR4A2 and Parkinson disease.